| __timestamp | ADMA Biologics, Inc. | Jazz Pharmaceuticals plc |
|---|---|---|
| Wednesday, January 1, 2014 | 4823869 | 406114000 |
| Thursday, January 1, 2015 | 6745968 | 449119000 |
| Friday, January 1, 2016 | 8494742 | 502892000 |
| Sunday, January 1, 2017 | 18092835 | 544156000 |
| Monday, January 1, 2018 | 22502922 | 683530000 |
| Tuesday, January 1, 2019 | 25910757 | 736942000 |
| Wednesday, January 1, 2020 | 35050817 | 854233000 |
| Friday, January 1, 2021 | 42896889 | 1451683000 |
| Saturday, January 1, 2022 | 52458024 | 1416967000 |
| Sunday, January 1, 2023 | 59020000 | 1343105000 |
Data in motion
In the competitive world of biotechnology, understanding the financial strategies of leading companies can offer valuable insights. Jazz Pharmaceuticals plc and ADMA Biologics, Inc. have shown distinct trends in their Selling, General, and Administrative (SG&A) expenses from 2014 to 2023. Jazz Pharmaceuticals, a major player, has consistently outspent ADMA Biologics, with its SG&A expenses peaking at approximately $1.45 billion in 2021. This represents a staggering 250% increase from 2014. In contrast, ADMA Biologics, a smaller entity, has seen its SG&A expenses grow by over 1,100% during the same period, reaching nearly $59 million in 2023. This dramatic rise reflects ADMA's aggressive expansion and investment in its operations. These financial trajectories highlight the differing scales and strategies of these two companies, offering a fascinating glimpse into their operational priorities and market positioning.
Who Optimizes SG&A Costs Better? Johnson & Johnson or Jazz Pharmaceuticals plc
Sanofi or Jazz Pharmaceuticals plc: Who Manages SG&A Costs Better?
Regeneron Pharmaceuticals, Inc. vs Jazz Pharmaceuticals plc: SG&A Expense Trends
Operational Costs Compared: SG&A Analysis of Neurocrine Biosciences, Inc. and Jazz Pharmaceuticals plc
Selling, General, and Administrative Costs: Summit Therapeutics Inc. vs Jazz Pharmaceuticals plc
Summit Therapeutics Inc. and ADMA Biologics, Inc.: SG&A Spending Patterns Compared
Jazz Pharmaceuticals plc vs ADMA Biologics, Inc.: Annual Revenue Growth Compared
SG&A Efficiency Analysis: Comparing Jazz Pharmaceuticals plc and Celldex Therapeutics, Inc.
Alpine Immune Sciences, Inc. vs ADMA Biologics, Inc.: SG&A Expense Trends
Cost Management Insights: SG&A Expenses for ADMA Biologics, Inc. and Rhythm Pharmaceuticals, Inc.
ADMA Biologics, Inc. and Xenon Pharmaceuticals Inc.: SG&A Spending Patterns Compared
SG&A Efficiency Analysis: Comparing ADMA Biologics, Inc. and BioCryst Pharmaceuticals, Inc.